Last reviewed · How we verify
NCT06262880
Dietary Supplementation on Gastrointestinal Barrier Function
NA trial testing plant derived phenolics in Intestinal Permeability in 126 participants. Status unknown.
20 December 2024
Quick facts
| Lead sponsor | Brightseed |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 126 |
| Start date | 6 February 2024 |
| Primary completion | 20 December 2024 |
| Estimated completion | 6 February 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- plant derived phenolics
- Microcrystaline cellulose (MCC)
Conditions studied
- Intestinal Permeability — all drugs for Intestinal Permeability →
Sponsor
Brightseed
Who can join
Adults 30 to 69, any sex, with Intestinal Permeability. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the current study is to examine the effects of a dietary supplement containing plant derived phenolics at two different dose levels on parameters of gastrointestinal (GI) health in otherwise generally healthy adults with risk factors (high BMI and waist circumference) for increased GI permeability. The primary hypothesis is that supplementation with plant derived phenolics will improve gut health compared to placebo.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06262880
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intestinal Permeability
Currently open trials in the same condition.
- NCT04083950 — Induction of Gut Permeability by an Oral Vaccine · EARLY_PHASE1 · active not recruiting
Other Brightseed trials
Trials by the same sponsor.
- NCT06548048 — Dietary Supplementation on Fat Oxidation · NA · recruiting
- NCT06417840 — To Evaluate the Impact of Consumption of a Bioactive Compound on Fasting Blood Glucose Levels in Asian Indians With Pre- · NA · recruiting
- NCT06296251 — Dietary Supplementation on Body Fat Composition · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06262880 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brightseed
- Last refreshed: 8 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06262880.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing